In contemporary clinical neuropharmacology, few botanical derivatives command as much scientific scrutiny and therapeutic interest as the active indole alkaloids derived from the Tabernanthe iboga shrub. As researchers and medical practitioners across the United States, United Kingdom, Germany, Japan, China, Canada, France, Netherlands, Switzerland, Australia, Dubai, Finland, and Austria evaluate advanced addiction interventions, standardized oral […]